EP3854388
Gegnum húðar meðferðarkerfi sem inniheldur rótígótín og að minnsta kosti eitt ekki-amín-þolið silíkon-viðloðunarefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.1.2020EP published:
4.10.2023EP application number:
20153621.6
EP translation filed:
27.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
23.1.2040Expiry date:
23.1.2027Next due date:
31.1.2027
Title in English:
TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVELanguage of the patent:
German
Timeline
Today
24.1.2020EP application
4.10.2023EP Publication
27.11.2023Translation submitted
15.12.2023Registration published
23.1.2027Expires
Owner
Name:
Luye Pharma Switzerland AGAddress:
Bäumleingasse 22, 4051 Basel, CH
Inventor
Name:
BENDA, ChristianAddress:
83607 Holzkirchen, DE
Name:
KOLLING, UlrikeAddress:
83026 Rosenheim, DE
Name:
SCHURAD, BjörnAddress:
80897 München, DE
Name:
WAUER, GabrielAddress:
83727 Schliersee, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 9/70, A61K 31/381, A61P 25/16
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.1.2024
Expires: 23.1.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 20.1.2025
Expires: 23.1.2026
Payer: Árnason Faktor ehf.
Number: 7
Paid: 21.1.2026
Expires: 23.1.2027
Payer: Árnason Faktor ehf.